Hypertrophic remodelling in cardiac regulatory myosin light chain (<i>MYL2</i>) founder mutation carriers
Godelieve R.F. Claes(Maastricht University Medical Centre), Arthur van den Wijngaard(Maastricht University Medical Centre), S. H. H. Kuijpers(Radboud University Nijmegen), Han G. Brunner(Radboud University Nijmegen), Carlo Marcelis(Radboud University Nijmegen), Simone Salemink(Radboud University Nijmegen), Imke Christiaans(Academic Medical Center), Andreas Perrot(Max Delbrück Center), Aimée Paulussen(Maastricht University Medical Centre), Paul G.A. Volders(Maastricht University Medical Centre), Marije B. Hoos(Maastricht University), Maarten P. van den Berg(University Medical Center Groningen), Johanna W. H. Janssen(Maastricht University Medical Centre), Jan-Willem E. M. Sels(Maastricht University Medical Centre), Ingrid P.C. Krapels(Maastricht University Medical Centre), J. Peter van Tintelen, Apollonia T.J.M. Helderman-van den Enden(Maastricht University Medical Centre), Wilfred F. Heesen(VieCuri Medisch Centrum), Florence H. J. van Tienen(Maastricht University Medical Centre), Patrick Lindsey(Maastricht University Medical Centre), Pablo García‐Pavía(Universidad Francisco de Vitoria), Yvette E.G. Barrois(Maastricht University Medical Centre)
Cited by 78
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Abnormal Behavior Associated with a Point Mutation in the Structural Gene for Monoamine Oxidase A
|Science|1993|1.6k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
|European Heart Journal|2015|1.1k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k